Matches in Nanopublications for { ?s ?p "[Analysis of 209 neuroblastoma patient tumors revealed that, in contrast with ABCC1 and ABCC4, low rather than high ABCC3 expression was associated with reduced event-free survival (HR of recurrence or death = 2.4, 95% CI = 1.4 to 4.2; P = .001), with 23 of 53 patients with low ABCC3 expression experiencing recurrence or death compared with 31 of 155 patients with high ABCC3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP690203.RAghK6qlw3nejZyYOV1FPsOHB_UG-QRjxcRcOis3hhQ18130_assertion description "[Analysis of 209 neuroblastoma patient tumors revealed that, in contrast with ABCC1 and ABCC4, low rather than high ABCC3 expression was associated with reduced event-free survival (HR of recurrence or death = 2.4, 95% CI = 1.4 to 4.2; P = .001), with 23 of 53 patients with low ABCC3 expression experiencing recurrence or death compared with 31 of 155 patients with high ABCC3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690203.RAghK6qlw3nejZyYOV1FPsOHB_UG-QRjxcRcOis3hhQ18130_provenance.
- NP319353.RA0M2gy_boEORdN5CIK9_xFm_me7X790eBatgLgpJLKqE130_assertion description "[Analysis of 209 neuroblastoma patient tumors revealed that, in contrast with ABCC1 and ABCC4, low rather than high ABCC3 expression was associated with reduced event-free survival (HR of recurrence or death = 2.4, 95% CI = 1.4 to 4.2; P = .001), with 23 of 53 patients with low ABCC3 expression experiencing recurrence or death compared with 31 of 155 patients with high ABCC3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP319353.RA0M2gy_boEORdN5CIK9_xFm_me7X790eBatgLgpJLKqE130_provenance.
- NP704991.RA5nITYMw2dSHou15KTtKNQANepEstSAL-BLMgEFFtxNY130_assertion description "[Analysis of 209 neuroblastoma patient tumors revealed that, in contrast with ABCC1 and ABCC4, low rather than high ABCC3 expression was associated with reduced event-free survival (HR of recurrence or death = 2.4, 95% CI = 1.4 to 4.2; P = .001), with 23 of 53 patients with low ABCC3 expression experiencing recurrence or death compared with 31 of 155 patients with high ABCC3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP704991.RA5nITYMw2dSHou15KTtKNQANepEstSAL-BLMgEFFtxNY130_provenance.
- NP569450.RArVJf9-Q4lMPqIZbIRiG3CIuz1sfaSjQGdGqK4Rjrqg8130_assertion description "[Analysis of 209 neuroblastoma patient tumors revealed that, in contrast with ABCC1 and ABCC4, low rather than high ABCC3 expression was associated with reduced event-free survival (HR of recurrence or death = 2.4, 95% CI = 1.4 to 4.2; P = .001), with 23 of 53 patients with low ABCC3 expression experiencing recurrence or death compared with 31 of 155 patients with high ABCC3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569450.RArVJf9-Q4lMPqIZbIRiG3CIuz1sfaSjQGdGqK4Rjrqg8130_provenance.
- NP802477.RA3lN9a9HKvYxxfVi24SATrLV63SZT0u3N9WiRvmbSrIM130_assertion description "[Analysis of 209 neuroblastoma patient tumors revealed that, in contrast with ABCC1 and ABCC4, low rather than high ABCC3 expression was associated with reduced event-free survival (HR of recurrence or death = 2.4, 95% CI = 1.4 to 4.2; P = .001), with 23 of 53 patients with low ABCC3 expression experiencing recurrence or death compared with 31 of 155 patients with high ABCC3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802477.RA3lN9a9HKvYxxfVi24SATrLV63SZT0u3N9WiRvmbSrIM130_provenance.